Understanding ANCA-Associated Vasculitis Relapse from Upper Airway Changes
Molecular and clinical predictors of relapse in ANCA-associated vasculitis
This project aims to find early signs in the nose that can tell us when ANCA-associated vasculitis (AAV) might come back, helping doctors better manage the disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-11141014 on NIH RePORTER |
What this research studies
ANCA-associated vasculitis (AAV) is a serious condition that affects many organs, and it often starts with problems in the upper airway, like the nose. It's hard to know when AAV might flare up again, which means patients often take strong medications for a long time. This project looks closely at changes in nasal genes and bacteria, as well as patient-reported symptoms, to see if these can predict a relapse before it happens. By understanding these early warning signs, we hope to help doctors make better decisions about treatment, potentially reducing the need for long-term, strong medications.
Who could benefit from this research
Good fit: Patients with ANCA-associated vasculitis who are currently in remission but are at risk for future relapses would be most relevant to this research.
Not a fit: Patients without ANCA-associated vasculitis or those not experiencing remission would likely not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to predict AAV relapses, allowing for more targeted treatment and potentially reducing the need for long-term, strong medications.
How similar studies have performed: This project builds on preliminary data showing that nasal changes can be detected before a systemic relapse, suggesting a promising foundation for this approach.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Rhee, Rennie — University of Pennsylvania
- Study coordinator: Rhee, Rennie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.